US Bancorp’s Viking Therapeutics, Inc. VKTXW Stock Holding History

US Bancorp’s Portfolio VKTXW Stock Details VKTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,000	Closed	-$18K	–	3692
2018 Q4	$18K	Hold	3,000	–	–	﹤0.01%	2862
2018 Q3	$48K	Hold	3,000	–	–	﹤0.01%	2586
2018 Q2	$24K	Buy	+3,000	New	+$15.7K	﹤0.01%	2881

Other funds holding VKTXW

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

OFG

OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

US Bancorp's VKTXW Position: Q1 2019 in Review

US Bancorp sold out of Viking Therapeutics, Inc. (VKTXW) in Q1 2019, closing a stake of 3,000 shares — an estimated $18K sold.

US Bancorp first reported a position in VKTXW in Q2 2018 and held it in 3 quarters. The position peaked at $48K in Q3 2018. 4 funds tracked by Wall St. Rank hold VKTXW as of Q1 2019.

US Bancorp reported no remaining Viking Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
US Bancorp sold 3,000 Viking Therapeutics, Inc. shares in Q1 2019, an estimated $18K.
US Bancorp first reported a position in Viking Therapeutics, Inc. in Q2 2018 and held it in 3 quarters.
US Bancorp's Viking Therapeutics, Inc. position peaked at $48K in Q3 2018.
4 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q1 2019.

Based on US Bancorp's 13F filing for Q1 2019, filed 8 May 2019.